Depression, Anxiety Clinical Trial
Official title:
Observational Study of Dronabinol Treatment for Depression and/or Anxiety in Older Patients
This is an observational study evaluating the safety and efficacy of dronabinol for the treatment of anxiety and/or depression in older adults. Participants who are prescribed dronabinol as part of a voluntary inpatient stay in McLean's Division of Geriatric Psychiatry will be interviewed about their mood and cognition on a weekly basis while on dronabinol.
Recently there has been renewed interest in potential alternative medical applications of
cannabis/THC and medical marijuana is now legalized in 23 states and the District of
Columbia. Acute effects of THC can include subjective feelings of euphoria, relaxation, and
sedation, and clinicians noted that THC is well tolerated for its approved indications. Given
these subjective effects and relatively benign safety profile, some physicians have used
dronabinol (synthetic THC) "off-label" to treat depression and/or anxiety.
The investigators are doing this research to better understand how effective dronabinol
treatment is when prescribed for depression and/or anxiety in older patients. The
investigators also want to find out if dronabinol is safe to take without causing too many
side effects. Dronabinol is is approved by the U.S. Food and Drug Administration (FDA) to
treat loss of appetite in chemotherapy patients, but dronabinol is not approved by the FDA to
treat depression and/or anxiety. Through research questionnaires on mood and cognition, the
investigators can gather information that will help demonstrate how effective dronabinol
treatment is at treating depression and/or anxiety.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04122482 -
An Online Course for Improving Knowledge and Access to Mental Health Accommodations in Canadian Enterprises
|
N/A | |
| Completed |
NCT04085861 -
Mental Health in Dancers; an Intervention Study
|
N/A | |
| Recruiting |
NCT06060210 -
Impact of Ketamine On Depressive Symptoms In Patients Undergoing Lumbo-peritoneal Shunt Insertion
|
Phase 4 | |
| Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
| Recruiting |
NCT06065787 -
NeuroGlove Anxiety and Depression Study
|
N/A | |
| Active, not recruiting |
NCT04583891 -
Mobile Apps to Reduce Distress in Breast Cancer Survivors Using an Adaptive Design
|
N/A | |
| Completed |
NCT05554042 -
Kintsugi Voice Device Study
|
||
| Not yet recruiting |
NCT06162624 -
Pilot Effectiveness Trial of an ACT Self-help Workbook Tailored Specifically for Prisons
|
N/A | |
| Completed |
NCT02954250 -
Mindfulness Based Cognitive Therapy for Depression and Cognitive Inhibition in Suicide
|
Early Phase 1 | |
| Recruiting |
NCT05647499 -
Evaluating the Back 2 School Program in a Norwegian Setting: A Multicenter Pilot Study
|
N/A | |
| Completed |
NCT03980873 -
Cognitive-Behavioral Therapy for Young Adult Lesbian, Gay and Bisexual: Transdiagnostic Minority Stress Approach
|
N/A | |
| Completed |
NCT04422327 -
The Impact of a Combination of Bifidobacterium Longum 35624® and 1714™ Strains in Adults With Irritable Bowel Syndrome
|
Phase 1/Phase 2 | |
| Completed |
NCT05368155 -
Chronic Pelvic Pain and Education Skills Training for Women Veterans
|
N/A | |
| Completed |
NCT05455905 -
Voice Biomarkers Predictive of Depression and Anxiety
|
||
| Completed |
NCT03272516 -
Mindfulness Based Cognitive Therapy (MBCT) for Primary Care Patients
|
N/A | |
| Not yet recruiting |
NCT06027047 -
Breakthrough Anxiety and Sleep Evaluation Using Linked Devices and Smartphone Application Onar (BASEL)
|
||
| Not yet recruiting |
NCT05535101 -
Non-invasive Brain Stimulation in Patients With Methamphetamine Use Disorder
|
N/A | |
| Recruiting |
NCT04418115 -
Fatigue as a Late Effect in Breast Cancer Survivors - is Acupuncture a Treatment Option?
|
N/A | |
| Completed |
NCT04905524 -
Activity Changes in Irritable Bowel Syndrome (IBS), Anxiety, and Depression Following the Use of Viome Precision Nutrition Program (VPNP)
|
N/A | |
| Recruiting |
NCT03953118 -
Azithromycin for Meibomian Gland Disease
|
Phase 4 |